Ofloxa-Vision Sine (Ofloxacin)

Ofloxacin belongs to the fluoroquinolone class and works by inhibiting bacterial DNA gyrase and topoisomerase IV. These enzymes are essential for DNA replication and transcription. By blocking them, ofloxacin prevents bacterial cells from multiplying, leading to a bactericidal effect against a broad range of ocular pathogens.

The dosing regimen for Ofloxa-Vision Sine is determined by the prescribing clinician based on the specific infection, severity, patient age and response to therapy. The prescriber will provide exact instructions on the number of drops, frequency and duration of treatment.

The pregnancy category for ofloxacin is not definitively established, and safety data are limited. Caution is advised when prescribing to pregnant or nursing women; the prescriber should weigh potential benefits against possible risks and consider alternative therapies if appropriate.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Ofloxa-Vision Sine contains ofloxacin, a broad‑spectrum fluoroquinolone that offers strong activity against both Gram‑negative and Gram‑positive ocular pathogens. Compared with older agents such as ciprofloxacin, ofloxacin often provides similar efficacy with a convenient dosing schedule and a favorable safety profile, though individual choice depends on local resistance patterns and clinician preference.

Store the ophthalmic solution at room temperature, preferably below 25 °C. Keep the bottle in its original packaging, protect it from direct light and moisture, and ensure the cap is tightly closed when not in use. Do not freeze the product.

The medication is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a small pocket, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption, and contact lenses should be avoided for at least 15 minutes.

Serious adverse events, although rare, include corneal ulceration or worsening of existing corneal lesions, severe allergic reactions such as swelling, itching or rash, and anaphylaxis, which requires immediate medical attention. Patients should be instructed to seek urgent care if they experience any of these symptoms.

Individuals with a known hypersensitivity to ofloxacin, other fluoroquinolones, or any component of the formulation should avoid using Ofloxa-Vision Sine. It is also contraindicated in patients who have experienced severe ocular reactions to fluoroquinolone eye drops in the past.